-
tumour fragment (PDTF) platform building on the ground-breaking work of collaborators at The Netherlands Cancer Institute (Voabil et al. 2021, Nature Medicine, Roelofsen et al. START Protocols, 2023). We
-
group leader at the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital in Amsterdam. He is also professor in translational immunotherapy of cancer at Leiden University Medical Centre and head of
Searches related to multi core
Enter an email to receive alerts for multi-core "The Netherlands Cancer Institute" positions